نتائج البحث - "sodium‐glucose co‐transporter"

1

Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis

المؤلفون: Giorgio Zanette, Paola Ponzani, Gaetano Serviddio, Giuseppe Memoli, Roberto Anichini, Patrizio Pasqualetti, Salvatore Caputo, Giulio Marchesini, Manfredi Rizzo, Veronica Resi

المساهمون: Marchesini G., Pasqualetti P., Anichini R., Caputo S., Memoli G., Ponzani P., Resi V., Rizzo M., Serviddio G., Zanette G.

المصدر: Acta Diabetologica. 56:289-299

مصطلحات موضوعية: Drug Administration Route, Endocrinology, Diabetes and Metabolism, Urogenital-tract infection, Type 2 diabetes, 030204 cardiovascular system & hematology, Logistic regression, choice behavior, 0302 clinical medicine, Endocrinology, Weight loss, italy, middle aged, Surveys and Questionnaire, urogenital-tract infections, humans, injectable drugs, glucagon-like peptide-1 receptor agonists, glucagon-like peptide-1 receptor, Sodium–glucose co-transporter 2 inhibitor, drug, dosage forms, General Medicine, dose frequency, nausea, Random effects model, aged, female, type 2, diabetes mellitus, Glucagon-like peptide-1 receptor agonist, medicine.symptom, Human, Adverse event, medicine.medical_specialty, Nausea, adverse events, oral treatment, route of delivery, sodium–glucose co-transporter 2 inhibitors, weight loss, body veight, diabetes mellitus, type 2, dose-response relationship, drug, drug administration routes, drug administration schedule, hypoglycemic agents, male, patient preference, surveys and questionnaires, Injectable drug, 030209 endocrinology & metabolism, Weight lo, dose-response relationship, 03 medical and health sciences, Route of administration, Internal medicine, Internal Medicine, medicine, Dosing, Adverse effect, Hypoglycemic Agent, Dose-Response Relationship, Drug, business.industry, Settore MED/09 - MEDICINA INTERNA, Body Weight, medicine.disease, Diabetes Mellitus, Type 2, business

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf28579ec7253a45644098848c7ffb2Test
https://doi.org/10.1007/s00592-018-1236-6Test

2

Role of SGLT2 inhibitors in the treatment of visceral obesity

المؤلفون: M. A. Druzhilov, T. Yu. Kuznetsova

المصدر: Кардиоваскулярная терапия и профилактика, Vol 20, Iss 1 (2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f3da848ba90c729af652232ba0059cTest
https://cardiovascular.elpub.ru/jour/article/view/2648Test

3

Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients

المؤلفون: Ming-Jui Hung, Swu Jane Lin, Shih Chieh Shao, Edward Chia Cheng Lai, Yuk Ying Chan, Yea Huei Kao Yang, Rong Nan Chien, Kai Cheng Chang

المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-11 (2020)

مصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, Databases, Factual, Endocrinology, Diabetes and Metabolism, Taiwan, Renal function, Blood Pressure, Type 2 diabetes, Pharmacology, Kidney, Multi-institutional electronic medical records, Internal medicine, Diabetes mellitus, medicine, Humans, Comparative effectiveness research, Sodium-Glucose Transporter 2 Inhibitors, Dipeptidyl peptidase-4, Aged, Retrospective Studies, Original Investigation, Glycated Hemoglobin, Real-world evidence, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Body Weight, Retrospective cohort study, Alanine Transaminase, Middle Aged, medicine.disease, Blood pressure, Treatment Outcome, Dipeptidyl peptidase 4 inhibitors, Diabetes Mellitus, Type 2, lcsh:RC666-701, Sodium/Glucose Cotransporter 2, Female, SGLT2 Inhibitor, Cardiology and Cardiovascular Medicine, business, Sodium glucose co-transporter 2 inhibitors, Biomarkers, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48331637a4afbf56d553cc4f4519ff4dTest
https://pubmed.ncbi.nlm.nih.gov/32050968Test

4

Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview

المؤلفون: Lance Sloan, Jaime A. Davidson

المصدر: Advances in Therapy

مصطلحات موضوعية: Blood Glucose, Combination therapy, endocrine system diseases, Efficacy, medicine.drug_class, Fixed-dose combination, 030209 endocrinology & metabolism, Blood Pressure, Type 2 diabetes, Review, Pharmacology, Hypoglycemia, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Double-Blind Method, Glucosides, Type 2 diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Pharmacology (medical), 030212 general & internal medicine, Canagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Glycemic, Medicine(all), business.industry, Body Weight, nutritional and metabolic diseases, General Medicine, medicine.disease, Sulfonylurea, Metformin, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Hyperglycemia, Drug Therapy, Combination, Safety, business, Sodium glucose co-transporter 2 inhibitors, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f27ee8de70db4a43b3331660a950cb25Test
http://europepmc.org/articles/PMC5216068Test

5

Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period

المؤلفون: Hyosung Kim, Toshitaka Yajima, Eiichi Araki, Michiko Asano, Ella Ekholm, Yukiko Onishi, Eva Johnsson

المصدر: Journal of Diabetes Investigation

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Type 2 diabetes, 030204 cardiovascular system & hematology, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Japan, Insulin, Sodium‐glucose co‐transporter 2 inhibitor, Dapagliflozin, Articles, General Medicine, Middle Aged, Clinical Trial, Clinical Science and Care, Treatment Outcome, Drug Therapy, Combination, Female, medicine.medical_specialty, Urology, 030209 endocrinology & metabolism, Hypoglycemia, Placebo, 03 medical and health sciences, Asian People, Double-Blind Method, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Benzhydryl Compounds, Aged, Glycemic, Glycated Hemoglobin, Add on to insulin, business.industry, Body Weight, medicine.disease, Interim analysis, Endocrinology, Diabetes Mellitus, Type 2, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9231f4b4c7f2a4bbaea5de79695977e4Test
https://doi.org/10.1111/jdi.12453Test

6

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

المؤلفون: A. Januszewicz, William Canovatchel, Gary Meininger, Fernando J. Lavalle-González, Rong Qiu, Cindy Tong, Jaime A. Davidson

المصدر: Diabetologia

مصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, Adolescent, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Blood Pressure, Thiophenes, Type 2 diabetes, Pharmacology, Placebo, Article, Sitagliptin Phosphate, law.invention, Glucosides, Randomized controlled trial, law, Internal medicine, Type 2 diabetes mellitus, Internal Medicine, medicine, Sitagliptin, Humans, Hypoglycemic Agents, Canagliflozin, Aged, Aged, 80 and over, Glycated Hemoglobin, business.industry, Body Weight, Fasting, Middle Aged, Triazoles, medicine.disease, Lipids, Metformin, Clinical trial, Treatment Outcome, Diabetes Mellitus, Type 2, Sodium glucose co-transporter 2 (SGLT2) inhibitor, Pyrazines, Drug Therapy, Combination, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5fd11d3c73ef1728b7795454497108aTest
https://doi.org/10.1007/s00125-013-3039-1Test

7

Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study

المصدر: Journal of Clinical Medicine Research

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8409387c06446f2134869f8c7de8e0Test
https://pubmed.ncbi.nlm.nih.gov/27081422Test

8

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

المؤلفون: Elias David-Neto, Liwen Xi, J-F Yale, K. Figueroa, George L. Bakris, Keith Usiskin, Dennis K. Yue, Gary Meininger, Bertrand Cariou, Ewa Wajs

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, Type 2 diabetes, Comorbidity, chemistry.chemical_compound, Endocrinology, Glucosides, Blood urea nitrogen, Canagliflozin, sodium glucose co-transporter 2 (SGLT2) inhibitor, Treatment Outcome, Urinary Tract Infections, Disease Progression, Female, type 2 diabetes, medicine.drug, Glomerular Filtration Rate, medicine.medical_specialty, Urology, Renal function, Thiophenes, Placebo, Drug Administration Schedule, Double-Blind Method, Sodium-Glucose Transporter 2, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Glycated Hemoglobin, Creatinine, Dose-Response Relationship, Drug, business.industry, diabetic nephropathy, Body Weight, Original Articles, medicine.disease, Diuresis, chemistry, Diabetes Mellitus, Type 2, business, Biomarkers, Kidney disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::197b1c34f3c1b8df861b298e13915710Test
https://pubmed.ncbi.nlm.nih.gov/23464594Test

9

The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials

المؤلفون: Mikkel Christensen, Lise Lotte Gluud, Heidi Storgaard, Tina Vilsbøll, Filip K. Knop

المصدر: BMJ Open

مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, Blood Pressure, Thiophenes, Type 2 diabetes, Cochrane Library, sodium-glucose co-transporter 2 inhibitor, Body Mass Index, Insulin resistance, Glucosides, ORAL MEDICINE, Internal medicine, Diabetes mellitus, Protocol, medicine, Humans, Benzhydryl Compounds, Canagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Randomized Controlled Trials as Topic, Glycated Hemoglobin, business.industry, Body Weight, General Medicine, medicine.disease, Surgery, Renal glucose reabsorption, meta-analysis, Clinical trial, Renal Elimination, Diabetes and Endocrinology, Treatment Outcome, Diabetes Mellitus, Type 2, Meta-analysis, Insulin Resistance, business, Systematic Reviews as Topic, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f1d734a14644a27dfbf7ad6028fd6bTest
https://doi.org/10.1136/bmjopen-2014-005378Test

10

Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin

المؤلفون: Ujjwala Vijapurkar, William Canovatchel, Lawrence A. Leiter, Gisle Langslet, Michael J. Davies

المصدر: Diabetes Therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a4eec7bd0d89f6eedcc533ef35ac93Test

تنقيح النتائج